Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma
Open Access
- 27 September 1996
- journal article
- research article
- Published by Wiley in International Journal of Cancer
Abstract
We describe the use of an immunotoxin (IT) cocktail (anti‐CD22‐ and anti‐CD19‐ricin A chain) and any 1 of 3 chemotherapeutic drugs (doxorubicin, cytoxan or camptothecin) to treat advanced disseminated Daudi lymphoma in SCID mice (SCID/Daudi). In a previous report, we demonstrated that this regimen was curative when given the day following tumor cell inoculation. Here, we show that combination therapy in mice with advanced tumor significantly increased their survival, although it was not curative. Importantly, the outcome of therapy was dependent upon the temporal order in which IT and chemotherapy were administered. Thus, the best anti‐tumor effect was achieved when an IT cocktail was given before or at the same time as chemotherapy. When the IT was given after chemotherapy, there was no additional therapeutic benefit. Our results confirm the rationale of using combination therapy in the treatment of advanced B‐cell neoplasia and suggest that ITs should be administered prior to or during chemotherapy. © 1996 Wiley‐Liss, Inc.Keywords
This publication has 15 references indexed in Scilit:
- Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: a phase I studyBlood, 1995
- Escape mechanisms of human leukemic cells to long‐term immunotoxin treatment in an in vitro experimental modelInternational Journal of Cancer, 1995
- Molecular mechanisms of drug resistance in tumoursThe Journal of Pathology, 1995
- Recent developments in immunotoxin therapyCurrent Opinion in Immunology, 1994
- Alkylating agents and immunotoxins exert synergistic cytotoxic activity against ovarian cancer cells. Mechanism of action.Journal of Clinical Investigation, 1993
- The intriguing link between modulation of both multidrug resistance and ligand-toxin conjugate cytotoxicityFEBS Letters, 1993
- Disseminated or localized growth of a human B‐cell tumor (Daudi) in scid miceInternational Journal of Cancer, 1990
- A monoclonal antibody-Pseudomonas toxin conjugate that specifically kills multidrug-resistant cells.Proceedings of the National Academy of Sciences, 1987
- Thioridazine enhances lysosomal accumulation of epidermal growth factor and toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxinExperimental Cell Research, 1986
- Verapamil enhances the toxicity of conjugates of epidermal growth factor with Pseudomonas exotoxin and antitransferrin receptor with pseudomonas exotoxinJournal of Cellular Physiology, 1984